Latest news from CURE

CURE

MDT Reform
Personalised Care
CURE
Prehab4Cancer
Lymphoedema

The CURE project is a comprehensive secondary care treatment programme for tobacco addiction. The aim of the programme are to systematically identify all active smokers admitted to secondary care and immediately offering nicotine replacement therapy and other medications, as well as specialist support for the duration of the admission and after discharge.

The term CURE has been specifically chosen to ‘medicalise’ tobacco addiction and move away from the stigma of a lifestyle choice to disease treatment. Treating tobacco addiction must become part of the core activity of all clinicians in every part of the hospital.

By applying the Ottawa Model outcomes to the estimated 52,780 smokers admitted to acute hospitals in Greater Manchester over the course of 1 year, the following benefits are expected:

  • If 13.3% were readmitted at 30 days and we reduced that to 7.1% we would save 3,273 admissions at 30 days

  • If 38.4% were re-admitted within 1 year and we reduced it to 26.7% we would save 6,176 admissions at 1 year

  • If 11.4% died within 1 year and we reduced that to 5.45% we would save 3,141 lives in 1 year

  • 18,473 successful 4-week quitters in the first year

The estimated savings from prevention of readmissions by applying the Ottawa Model to Greater Manchester is £9,937,184 per year.

Furthermore, the average length of hospital stay in England is 5 days (NGS Digital Data 2015-2016). The CURE project is estimated to save 30,880 bed days per year, equivalent to 84 additional beds per day across Greater Manchester.

Visit the CURE website
Image of CURE team with stand up banner

Links to other useful sites

Do you want to be the first to know about what's on in Manchester?

Greater Manchester Cancer will let you know of upcoming education and engagement events across GM.

Select your preferences and sign up here!